Showing results (71-80 of 943) with videos related to
Sort By:
Pageof 95
Leprosy Review|February 24, 2001
Leprosy: between acceptance and segregation. Community behaviour towards persons affected by leprosy in eastern NepalD H de Stigter, L de Geus, M L HeyndersLeprosy Review|February 24, 2001
Stigma reduction through group counselling of persons affected by leprosy--a pilot studyM Floyd-Richard, S GurungLeprosy Review|February 15, 2011
Lessons from the evolution of a CBR programme for people affected by leprosy in Northern NigeriaBassey Ebenso, Michael Idah, Terver Anyor, et al.Leprosy Review|November 12, 2010
Decentralisation of leprosy control activities in the municipality of Betim, Minas Gerais State, BrazilPriscila Leiko Fuzikawa, Francisco Assis De Acúrcio, Johan P Velema, et al.Leprosy Review|November 12, 2010
Review of leprosy research evidence (2002-2009) and implications for current policy and practiceWim van Brakel, Hugh Cross, Etienne Declercq, et al.Leprosy Review|September 1, 1991
Immunological upgrading with combined immunotherapy and chemotherapy in a lepromatous leprosy patient: a case reportS A Zaheer, N R Suresh, H K Kar, et al.Leprosy Review|September 1, 1991
Is bacteriological examination by skin smear necessary in all paucibacillary leprosy patients in mass control programmes?P S Rao, V Ekambaram, B N Reddy, et al.Leprosy Review|May 24, 2007
Community dermatology inclusive of leprosy: its past present and futureTerence J RyanLeprosy Review|September 1, 1990
The anatomical distribution of single leprosy lesions in an African population, and its implications for the pathogenesis of leprosyJ M Ponnighaus, P E Fine, P J Gruer, et al.Leprosy Review|December 1, 2011
Does clofazimine prevent erythema nodosum leprosum (ENL) in leprosy? A retrospective study, comparing the experience of multibacillary patients receiving either 12 or 24 months WHO-MDTMarivic Balagon, Paul R Saunderson, Robert H GelberPageof 95